Friday, February 3, 2023
HomeFactsSurvival Rate Metastatic Breast Cancer

Survival Rate Metastatic Breast Cancer

Disease Free Intervals And Prognosis In Metastasis

A New Breast Cancer Treatment Could Be A Game Changer

The time that passes between the primary diagnosis and treatment of breast cancer and a diagnosis of metastasis is also of prognostic significance.

A 2015 medical study from the Netherlands looked at 815 patients with metastatic breast cancer between 2007 and 2009 in eight hospitals.

Of these 815 patients, 154 had metastatic spread at diagnosis. 176 patients had a metastatic free interval of less than 2 years and 485 patients had been metastasis-free for longer than 2 years.

The ladies presenting with metastatic breast cancer at diagnosis had a longer survival rate than those who experienced a recurrence at distant sites in under 2 years from the initial diagnosis of breast cancer.

However, there were no differences in survival rates between those diagnosed at Stage IV and those women who had metastatic spread over 2 years after an original breast cancer diagnosis and treatment.

Furthermore, some medical studies show that survival rates vary for different types and subtypes of breast tumors according to the time intervals of recurrence. So, for example, breast cancer survival rates comparing two cancers may be better at a 5-year interval for some cancers but even out over 15 years.

Survival Rate With Metastatic Breast Cancer

Many people wonder about the life expectancy for stage 4 breast cancer . It’s important to note that everyone is different and survival rates vary widely. There are some people who survive many years and even decades with stage 4 disease. At the same time, it’s important to understand that stage 4 breast cancer isn’t curable.

It can be helpful to look at current statistics and consider the many variables that affect life expectancy. While it’s important not to raise false hope, it may help to know the reality that there are some long-term survivors.

Some people want to know the statistics, but many don’t. If you’re living with stage 4 breast cancer, there is absolutely no requirement that you know the prognosis. The information provided here is only for those who truly wish to know what the current research iseven this research has many limitations.

Can You Predict Cancer Survival

Keep in mind that survival rates are estimates and are often based on previous outcomes of large numbers of people who had a specific cancer, but they cant predict what will happen in any particular persons case. These statistics can be confusing and may lead you to have more questions. Talk with your doctor about how these numbers may apply to you, as he or she is familiar with your situation.

Also Check: Does Hitting Your Breast Cause Cancer

Breast Cancer Survival Rates In Men

Survival rates can give you an idea of what percentage of people with the same type and stage of cancer are still alive a certain amount of time after they were diagnosed. They cant tell you how long you will live, but they may help give you a better understanding of how likely it is that your treatment will be successful.

Keep in mind that survival rates are estimates and are often based on previous outcomes of large numbers of people who had a specific cancer, but they cant predict what will happen in any particular persons case. These statistics can be confusing and may lead you to have more questions. Ask your doctor how these numbers might apply to you, as they are familiar with your situation.

The Importance Of Screening

Study estimates number of U.S. women living with metastatic breast ...

If youve been diagnosed with breast cancer, and especially if you have higher risk due to a hereditary gene mutation or other factors, screening can mean earlier detection of a recurrence or new breast cancer. Regular breast cancer screenings have been shown to reduce the risk of dying from breast cancer and increase survival rates.

Talk with your healthcare team about the type of screening plan thats best for you.

Below you can find articles, personal stories, and downloadable resources with more information about diagnosis, talking with family, and finding emotional support.

You May Like: What Is The Average Age For Breast Cancer

Metastatic Breast Cancer Statistics

1 in 8 women will be diagnosed with breast cancer in the US and 1 in 3 of those will become metastatic. African American women are 40% more likely to die from breast cancer than Caucasian women.

Men get breast cancer too. All people, male and female, are born with some breast cells and tissue. Even though males do not develop milk-producing breasts, a mans breast cells and tissue can still develop cancer. Male breast cancer is rare. Less than one percent of all breast cancer cases develop in men, and only one in a thousand men will be diagnosed with breast cancer and only about 2% will metastasize.

In 2019, its estimated that among U.S. women and men there will be 268,600 new cases of advanced breast cancer and 41,760 breast cancer deaths. Of those deaths, it is estimated that 97-99% of those will be from metastatic breast cancer. Men get breast cancer too. It is estimated that there will be 2670 new male breast cancer diagnosis in 2019 and 500 of those will die due to metastatic breast cancer.

Study Estimates Number Of Us Women Living With Metastatic Breast Cancer

240-760-6600

A new study shows that the number of women in the United States living with distant metastatic breast cancer , the most severe form of the disease, is growing. This is likely due to the aging of the U.S. population and improvements in treatment. Researchers came to this finding by estimating the number of U.S. women living with MBC, or breast cancer that has spread to distant sites in the body, including women who were initially diagnosed with metastatic disease, and those who developed MBC after an initial diagnosis at an earlier stage.

The researchers also found that median and five-year relative survival for women initially diagnosed with MBC is improving, especially among younger women.

The study was led by Angela Mariotto, Ph.D., chief of the Data Analytics Branch of the Division of Cancer Control and Population Sciences at the National Cancer Institute , with coauthors from NCI, the Metastatic Breast Cancer Alliance, and the Fred Hutchinson Cancer Research Center. The findings appeared online on May 18, 2017, in Cancer Epidemiology, Biomarkers & Prevention. NCI is part of the National Institutes of Health.

Reference

Recommended Reading: Can Asbestos Cause Breast Cancer

Coping With Advanced Breast Cancer

Being told that you have advanced or metastatic breast cancer may be very confronting or overwhelming. Some women also find the news that their cancer has spread or come back is more devastating than their original diagnosis.

There are many resources available online to help you further understand the meaning of your diagnosis and how to manage the emotional, physical and practical issues arising from metastatic breast cancer. Below are some links where these resources can be accessed:

Although support groups can provide a safe place for people to express their feelings amongst others who share a similar experience, some people are more comfortable talking one-on-one, such as with a counsellor, therapist or trained volunteer . Your GP can also refer you to a psychologist, social worker or other trained therapist. Every person is different and it is important to find a healthy support system that works for you.

A Note From Dr Halls Regarding The Statistics For Metastatic Recurrence In Breast Cancer

Understanding Breast Cancer Survival Rates

The statistic of 20% to 30% for metastatic breast cancer that recurs remain controversial amongst medical experts. The figure of 30% metastatic breast cancer recurrence rate first appears in a 2005medical study, but no statistical data or sources are cited.

The MBCN take the 18-year relative survival rate from the SEERS data between the years of 1990 to 1994 as 71%. The argument is, that this takes us close to the 30% recurrence rate statistic. However, there are many other factors at play and treatment has advanced so much that recurrence rates may have even halved since then.

It is safe to say that much more data and research into metastatic recurrence rates would be of huge value towards a long-term cancer cure.

Indeed, it has also been suggested that research into the rare group of women who survive many years with metastasis may be of equal importance to understanding recurrence and patterns of breast cancer.

Recommended Reading: Diet During Chemotherapy For Breast Cancer

Can Stage 4 Breast Cancer Go Into Remission

Stage 4 breast cancer can go into remission, meaning that it isnt detected in imaging or other tests. Pathological complete remission indicates a lack of cancer cells in tissues removed after surgery or biopsy.

But its rare to take tissue samples while treating stage 4 breast cancer. This could mean that although treatment has been effective, it hasnt completely destroyed the cancer.

Advances in stage 4 breast cancer treatments are helping to increase the length of remission.

Treatment For Advanced Breast Cancer

Treatment of metastatic breast cancer aims to control the growth and spread of the cancer, to relieve symptoms, reduce pain, and improve or maintain quality of life.

The treatment recommended by doctors will depend on which treatments are likely to control the breast cancer and what side effects the person can cope with. Treatment options may involve:

Recommended Reading: What Is Stage 4 Cancer Breast Cancer

What Is A 5

A relative survival rate compares women with the same type and stage of breast cancer to women in the overall population.For example, if the 5-year relative survival rate for a specific stage of breast cancer is 90%, it means that women who have that cancer are, on average, about 90% as likely as women who dont have that cancer to live for at least 5 years after being diagnosed.

A Note About Statistics

De novo metastatic breast cancer: Subgroup analysis of molecular ...

Survival rates are statistics. As such, they tend to tell us how the average person will do with an average triple-negative breast cancer. But people and tumors arent statistics. Some people will do better, and some people will do worse.

Very importantly, statistics are usually several years old. In order to calculate five-year survival rates, a person would have to have been diagnosed at least five years prior, and there is lag time. The treatment of triple-negative breast cancer is changing, and new drugs have been approved.

According to research from the National Cancer Institute , the number of women living with metastatic breast cancer in the United States is increasing at the same time, women with metastatic disease are living longer, especially younger women.

The research was published online on May 18, 2017 by the journal Cancer Epidemiology, Biomarkers & Prevention. Read the abstract of Estimation of the Number of Women Living with Metastatic Breast Cancer in the United States.

Metastatic breast cancer is breast cancer that has spread to parts of the body away from the breast, such as the bones or liver. Metastatic breast cancer is stage IV cancer. A woman can be diagnosed with metastatic disease when first diagnosed. Breast cancer also can come back in a part of the body away from the breast. This is called metastatic recurrence.

The study compared 5-year survival rates from 1992 to 1994 and from 2005 to 2012:

Don’t Miss: How Much Does Breastfeeding Reduce The Risk Of Breast Cancer

How Can I Take Care Of Myself While Living With Metastatic Breast Cancer

Living with metastatic breast cancer can be challenging. Your care team can help provide physical and emotional support. Talk to them about how you can:

  • Eat the most nutritious diet for your needs.
  • Exercise regularly.
  • Get emotional support, including finding support groups.
  • Reach out for help from friends, family and loved ones.
  • Find mental health services.
  • Find complementary therapies.

The Role Of Caregivers

Caregivers also play a vital role in helping a person with cancer be as comfortable as possible. To help, a caregiver can:

According to the American Society for Clinical Oncology, in 2018, doctors will diagnose invasive breast cancer in an estimated 268,670 people in the United States.

The ACS state that the 5-year relative survival rate for people with metastatic breast cancer is around 22 percent. This means that people with metastatic breast cancer are 22 percent as likely as people without the condition to live at least 5 years following diagnosis.

However, many factors can affect how long a person with metastatic breast cancer lives for, including:

  • the type of breast cancer
  • the stage of breast cancer
  • where the cancer has spread to
  • how well the cancer responds to treatment
  • any other health issues that the person has

Everyoneâs outlook is different. It is also important to note that survivals rates are just estimates, and that doctors base these figures on data from at least 5 years ago. Continuing advancements in cancer treatments means that survival rates are improving.

Also Check: What Treatments Are There For Breast Cancer

Some Prognostic Factors Follow Lognormal Distribution

Prognostic factors in patients with distant metastases at the time of diagnosis were investigated by Rudan et al. , and Chapman et al. , primary tumor size was a significant prognostic factor. Engel et al. found that the number of metastatic cases and the time to metastasis depended on the tumor diameter at diagnosis. Cell growth is essential for the development of tumors. Tumor size is therefore the most important factor in describing tumor biology. As the tumor size increases, the probability of node-positivity increases. Another study group also found this correlation up to 5 cm . Tubiana and Koscielny have found a highly significant correlation between tumor size and the probability of distant metastasis. The distribution of tumor sizes at metastatic spread was lognormal with a median diameter equal to 3.5 cm. The patients were subdivided into 3 groups according to the histological grade. In each subgroup there was a significant correlation between tumor size and the probability of distant spread. The distributions were lognormal and the median size was markedly larger for grade 1 tumors.

Table 4 Cancer sites with survival times demonstrated to follow the lognormal distribution in the literature as at year 2004

Can Metastatic Breast Cancer Go Into Remission

Breast Cancer Survival Rate

Metastatic breast cancer may never go away completely. But treatment can control its spread. Cancer may even go into remission at some points. This means you have fewer signs and symptoms of cancer.

A treatment break may be considered in certain situations, including if remission occurs or if someone is experiencing intolerable side effects. A pause in treatment can help you feel your best and improve your quality of life.

You May Like: Can Iodine Cure Breast Cancer

What Is Indiana Known For

For instance, the American Cancer Society cites stage 4 breast cancer survival rate at 22 percent over five years, and about 14 percent for stage 4 colon cancer. Similarly, stage 4 ovarian cancer has a five-year survival rate of. 2 days ago · Japan has historically had among the lowest rates of colon cancer,.

Eribulin Improves Survival Of Women With Metastatic Breast Cancer

Treatment with eribulin improved overall survival in women with metastatic breast cancer whose disease progressed despite multiple rounds of prior chemotherapy, according to the results of a phase III clinical trial called EMBRACE. Based on these findings, the FDA approved eribulin last November for women with metastatic disease who have already undergone at least two previous chemotherapy regimens.

The study results were published online March 2, 2011, in The Lancet.

The improvement in overall survival makes the findings clinically meaningful, wrote the studys lead author, Javier Cortes, M.D., of the Vall d’Hebron Institute of Oncology in Barcelona, Spain, and his colleagues. To our knowledge, EMBRACE is the first major single-agent study of a cytotoxic or biological agent to show significantly increased survival in patients with such heavily pretreated metastatic breast cancer.

Eribulin is a laboratory-made form of halichondrin B, a substance derived from a sea sponge. Similar to some other chemotherapy drugs, it targets the protein tubulin in cells, although it binds to tubulin in a different way, interfering with cancer cell division and growth.

The clinical gains from EMBRACE are sufficiently narrow, the study authors continued, that a better understanding of the relation between treatment, symptom control, and quality of life in study participants remains crucial.

  • Posted:June 10, 2011

You May Like: How Many New Cases Of Breast Cancer Each Year

What Treatments Are Used For Metastatic Cancer

Metastatic cancer may be treated with chemotherapy, biological therapy, targeted therapy, hormonal therapy, radiation therapy, surgery, or a combination of these treatments.

The choice of treatment generally depends on the type of primary cancer the size, location, and the number of metastatic tumors. Also, the patients age and general health and the types of treatment the patient has had in the past.

Clinical Trials Are A Promising Treatment Option

Click Here

For people with advanced stages of cancer, clinical trials can be considered the gold standard of treatment. I recommend clinical trials highly, says Rosen. You get access to medication and treatment that you normally wouldnt have.

A clinical trial could even have positive results on your cancer. We are living in an exciting time for cancer treatment, says Kimmick. There are myriad new drugs coming out that will improve the lives of all women with breast cancer, both metastatic and early stage.

However, its important to be realistic about the potential outcome of your trial. Rosen was recently enrolled in a clinical trial in which the medication proved toxic for her. But she has no regrets about participating. It feels like Im helping researchers who are working on cures for cancer, she says. When I had a bad reaction to the drug, they were able to put my side effects in their study. I feel like I did help, and that makes me happy.

People interested in joining a clinical trial for treatment should talk to their doctor about options that might be good for them.

Recommended Reading: What Happens When Breast Cancer Spreads To The Lymph Nodes

RELATED ARTICLES

Popular Articles